Ultrasensitive ctDNA detection improves risk prediction in early-stage lung cancer

Ultrasensitive ctDNA detection with NeXT Personal shows 81% sensitivity in early-stage lung adenocarcinoma, improving prognostic accuracy and therapy guidance.

Social Media Giant’s Efforts to Stymie Antivax Content Had Mixed Results

While Facebook’s policy on removing repeat offenders who post COVID-19 vaccine misinformation may have reduced the number of posts in anti-vaccine pages/groups, it has not

September 16, 2023

A new test could save arthritis patients time, money, and pain. But will it be used?

Erinn Maury knew Remicade wasn’t the right drug for Patti Schulte, a rheumatoid arthritis patient the physician saw at her Millersville, Maryland, practice. Schulte’s swollen,

December 20, 2023

New Medical Device ColdVest Can Prevent Heat-Related Deaths

What You Should Know: – ColdVentures, a medical device innovator, has unveiled the ColdVest – a groundbreaking wearable technology designed to prevent heat stroke fatalities.

June 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.